DUBLIN, Sept. 5, 2022 /PRNewswire/ -- The "Urea Breath Test Market, by Test Type, by Product, by Instrument, by End-user, and by Region" report has been added to ResearchAndMarkets.com's offering. The ...
This e-learning module gives an overview of the carbon-13 urea breath test (13 C-UBT) for Helicobacter pylori (H. pylori) infection. It describes a robust test for the diagnosis of gastric H. pylori ...
Asymptomatic Subjects. Sixty-five healthy, asymptomatic volunteers aged 54.2 ± 2.0 years (mean ± SEM; range 20 86 years) were involved in the present study. All subjects were initially screened for H.
Exalenz Bioscience’s flagship product is the BreathID® Hp test, a non-invasive urea in-office breath test designed to detect active H. pylori infections within minutes. Clinical studies have ...
Improving treatment in H pylori infection could lead to better outcomes in peptic ulcer disease, gastric cancer, gastric lymphoma, and functional dyspepsia. Tetracycline-based bismuth quadruple ...
CINCINNATI, July 23, 2021 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc., a leading global provider of diagnostic testing solutions and life science raw materials, announced today that it signed a ...
Background: Clinical guidelines for H. pylori screening and post-treatment testing endorse the use of urea breath test (UBT), H. pylori stool antigen test (HpSAT), and biopsy-related tests. Due to ...
WILMINGTON, Del.--(BUSINESS WIRE)--Exalenz Bioscience, Inc., a provider of breath testing equipment for the diagnosis and management of digestive system and liver conditions, today announced the ...
Rising resistance to clarithromycin and levofloxacin necessitates avoiding these in treatment regimens without susceptibility testing. Bismuth quadruple therapy is recommended for treatment-naive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results